1.
Su C. The efficiency, safety, and clinical potential of semorinemab in the treatment of Alzheimer’s disease. HSET [Internet]. 2024 Jun. 18 [cited 2026 Aug. 19];99:232-6. Available from: https://drpress.org/ojs/index.php/HSET/article/view/21566